<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, in cancer treatment, several anticancer drugs have been used with important side effects due to their close therapeutic margin and high toxicity. Moreover, the risks for infection are increased due to the small number of white blood cells (neutropenia) arising from the chemotherapy toxic effect on the bone marrow [
 <xref rid="B9" ref-type="bibr">9</xref>]. Due to its immunocompromised status, antimicrobial therapy is often undertaken in hospitalized cancer patients. However, the significant increase in use of antibiotics is associated with the appearance of multidrug-resistant pathogens such as 
 <italic>Staphylococcus aureus.</italic> This bacterium is the main nosocomial pathogen agent worldwide and the most worrisome, particularly 
 <italic>S. aureus</italic> resisting the methicillin (MRSA), as well as it is easily capable to develop in biofilms in hospitalized patients [
 <xref rid="B10" ref-type="bibr">10</xref>].
</p>
